X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (401) 401
Dissertation (2) 2
Magazine Article (2) 2
Patent (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (134) 134
gastroenterology & hepatology (120) 120
female (81) 81
male (76) 76
adult (63) 63
infliximab (63) 63
gastroenterology and hepatology (61) 61
life sciences (61) 61
ulcerative colitis (59) 59
crohns-disease (54) 54
middle aged (53) 53
gastroenterology (46) 46
crohn's disease (45) 45
oncology (44) 44
medicine & public health (43) 43
inflammatory-bowel-disease (39) 39
inflammatory bowel disease (37) 37
abdominal surgery (36) 36
colitis, ulcerative - drug therapy (36) 36
adalimumab (35) 35
gynecology (35) 35
interventional radiology (35) 35
urology/andrology (35) 35
therapy (31) 31
treatment outcome (31) 31
inflammatory bowel diseases (29) 29
aged (28) 28
crohn disease - drug therapy (28) 28
inflammatory bowel diseases - drug therapy (26) 26
prospective studies (26) 26
care and treatment (25) 25
remission (25) 25
antibodies (24) 24
analysis (23) 23
pharmacology & pharmacy (23) 23
maintenance therapy (22) 22
young adult (22) 22
[ sdv ] life sciences [q-bio] (20) 20
azathioprine (19) 19
ibd (19) 19
medical research (19) 19
medicine, experimental (19) 19
ulcerative-colitis (19) 19
retrospective studies (18) 18
france (17) 17
risk factors (17) 17
surgery (17) 17
human health and pathology (16) 16
hépatology and gastroenterology (16) 16
pharmacokinetics (16) 16
tumor necrosis factor-alpha - antagonists & inhibitors (16) 16
efficacy (15) 15
immunosuppressive agents - therapeutic use (15) 15
intestine (15) 15
patients (15) 15
prevalence (15) 15
follow-up studies (14) 14
gastrointestinal agents - therapeutic use (14) 14
mesh : humans (14) 14
tumor necrosis factor (14) 14
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (13) 13
abridged index medicus (13) 13
maintenance (13) 13
medicine, general & internal (13) 13
monoclonal antibodies (13) 13
severity of illness index (13) 13
antibodies, monoclonal - therapeutic use (12) 12
bacteriology (12) 12
diagnosis (12) 12
gastrointestinal diseases (12) 12
microbiology and parasitology (12) 12
prognosis (12) 12
remission induction (12) 12
adolescent (11) 11
consensus (11) 11
dose intensification (11) 11
multivariate analysis (11) 11
therapeutic drug monitoring (11) 11
[sdv.mp.bac]life sciences [q-bio]/microbiology and parasitology/bacteriology (10) 10
clinical-response (10) 10
immunology (10) 10
management (10) 10
trough levels (10) 10
virology (10) 10
anti-inflammatory agents - therapeutic use (9) 9
colitis, ulcerative - diagnosis (9) 9
colon (9) 9
crohn disease (9) 9
drug therapy, combination (9) 9
gastrointestinal agents - administration & dosage (9) 9
induction therapy (9) 9
logistic models (9) 9
mesh : female (9) 9
mesh : male (9) 9
molecular biology (9) 9
recurrence (9) 9
risk (9) 9
safety (9) 9
[sdv.imm]life sciences [q-bio]/immunology (8) 8
[sdv.mhep.heg] life sciences [q-bio]/human health and pathology/hepatology and gastroenterology (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 1/2017, Volume 52, Issue 1, pp. 19 - 25
Journal Article
by Amiot, Aurelien and Grimaud, Jean-Charles and Peyrin-Biroulet, Laurent and Filippi, Jerome and Pariente, Benjamin and Roblin, Xavier and Buisson, Anthony and Stefanescu, Carmen and Trang-Poisson, Caroline and Altwegg, Romain and Marteau, Philippe and Vaysse, Thibaud and Bourrier, Anne and Nancey, Stephane and Laharie, David and Allez, Matthieu and Savoye, Guillaume and Moreau, Jacques and Gagniere, Charlotte and Vuitton, Lucine and Viennot, Stephanie and Aubourg, Alexandre and Pelletier, Anne-Laure and Bouguen, Guillaume and Abitbol, Vered and Bouhnik, Yoram and Amiot, Aurelien and Zallot, Camille and Bigard, Marc-Andre and Hebuterne, Xavier and Nachury, Maria and Desreumaux, Pierre and Del Tedesco, Emilie and Bommelaer, Gilles and Boureille, Arnaud and Altwegg, Romain and Dray, Xavier and Carbonnel, Franck and Seksik, Philippe and Beaugerie, Laurent and Cosnes, Jacques and Sokol, Harry and Landman, Cecilia and Boschetti, Gilles and Poullenot, Florian and Gornet, Jean-Marc and Baudry, Clautilde and Koch, Stephane and Aubourg, Alexandre and Picon, Laurence and Sickersen, Gaelle and Chaussade, Stanislas and Nahon, Stephane and Winkfield, Betsy and Brixi-Benmansour, Hedia and Gincul, Rodica and Barberis, Jean-Christophe and Bonaz, Bruno and Michiels, Christophe and Zerbib, Franck and de Beauregard, Marie Bourrier and Locher, Christophe and Davin-Couve, Sophie and Poirette, Armelle and Guillem, Laurence and Stetiu-Mocanu, Monica and Beorchia, Sylvain and Al Qaddi, Jawad and Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group and Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif and Grp d'Etude Therapeutique des and Observatory Efficacy Vedolizumab
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 11, pp. 1593 - 1601.e2
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 7, p. e67810
Journal Article
Therapeutic advances in gastroenterology, ISSN 1756-2848, 2018, Volume 11, p. 175628481877278
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 2019, Volume 49, Issue 6, pp. 822 - 823
Linked ContentThis article is linked to Ungar et al and Echarri et al papers. To view these articles, visit https://doi.org/10.1111/apt.13862 and... 
DRUG | PHARMACOLOGY & PHARMACY | ANTIDRUG ANTIBODIES | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | IMMUNOMODULATOR | Antibody Formation | Immunologic Factors | Infliximab